Literature DB >> 9399514

Clinical and epidemiological significance of enterococci intrinsically resistant to vancomycin (possessing the vanC genotype)

B Toye1, J Shymanski, M Bobrowska, W Woods, K Ramotar.   

Abstract

Constitutive low-level vancomycin resistance is found intrinsically in certain enterococcal species and is encoded by vanC ligase genes. These intrinsically vancomycin-resistant enterococci (VRE) will be referred to as VANC VRE. A prospective study to determine the clinical and epidemiologic significance of VANC VRE was conducted. VANC VRE were recovered from the stools of 34 of 601 (5.7%) patients, a rate similar to that obtained for the stools of 100 outpatients in the community (5%). VANC VRE were also isolated from the nonstool specimens of 9 of 538 patients (1.7%), including two patients with bacteremia. No VRE of the vanA or vanB genotypes were detected in nonstool specimens. Eighty-two hospital contacts of the first 23 patients found to be colonized or infected with VANC VRE were screened, and 6 contacts were found to be gastrointestinal carriers of VANC VRE. However, typing of isolates from these 6 contacts by pulsed-field gel electrophoresis with SmaI showed the isolates to be unique and different from those recovered from the index patients. In fact, all VANC VRE isolates from different patients in this study were unique. A case-control study with patients who were negative when screened for VANC VRE as controls failed to identify any risk factor associated with colonization or infection with this organism. VANC VRE were infrequently recovered from clinical specimens but were occasionally found as part of the normal stool flora. Since no transmission between patients was documented, additional isolation procedures may not be necessary for patients colonized or infected with VANC VRE.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9399514      PMCID: PMC230142          DOI: 10.1128/jcm.35.12.3166-3170.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  The VANA glycopeptide resistance protein is related to D-alanyl-D-alanine ligase cell wall biosynthesis enzymes.

Authors:  S Dutka-Malen; C Molinas; M Arthur; P Courvalin
Journal:  Mol Gen Genet       Date:  1990-12

2.  Identification of Enterococcus species isolated from human infections by a conventional test scheme.

Authors:  R R Facklam; M D Collins
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

Review 3.  Genetics and mechanisms of glycopeptide resistance in enterococci.

Authors:  M Arthur; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

4.  Vancomycin susceptibility and identification of motile enterococci.

Authors:  S Vincent; R G Knight; M Green; D F Sahm; D M Shlaes
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

5.  Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study Group.

Authors:  S Gordon; J M Swenson; B C Hill; N E Pigott; R R Facklam; R C Cooksey; C Thornsberry; W R Jarvis; F C Tenover
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

6.  Recovery of vancomycin-resistant gram-positive cocci from pediatric liver transplant recipients.

Authors:  M Green; K Barbadora; M Michaels
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

7.  Development of a standardized screening method for detection of vancomycin-resistant enterococci.

Authors:  J M Swenson; N C Clark; M J Ferraro; D F Sahm; G Doern; M A Pfaller; L B Reller; M P Weinstein; R J Zabransky; F C Tenover
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

8.  Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens.

Authors:  F Navarro; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

9.  Vancomycin resistance gene vanC is specific to Enterococcus gallinarum.

Authors:  R Leclercq; S Dutka-Malen; J Duval; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

10.  Recovery of resistant enterococci during vancomycin prophylaxis.

Authors:  A H Kaplan; P H Gilligan; R R Facklam
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

View more
  29 in total

1.  Enterococcus gallinarum endocarditis occurring on native heart valves.

Authors:  Sylvie Dargere; Michel Vergnaud; Renaud Verdon; Eric Saloux; Olivier Le Page; Roland Leclercq; Claude Bazin
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

Review 2.  Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci.

Authors:  Stephan Harbarth; Sara Cosgrove; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

3.  Isolation and characterization of glycopeptide-resistant enterococci from hospitalized patients over a 30-month period.

Authors:  R R Nelson; K F McGregor; A R Brown; S G Amyes; H Young
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

4.  Evaluation of 15 motility media and a direct microscopic method for detection of motility in enterococci.

Authors:  Kenneth Van Horn; Clara Tóth; Reiko Kariyama; Ritsuko Mitsuhata; Hiromi Kumon
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

5.  Prevalence of vancomycin-resistant enterococcus in prenatal screening cultures.

Authors:  Melissa B Miller; Sonia L Allen; Mary Ellen Mangum; Anastassia Doutova; Peter H Gilligan
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

6.  Pretransplant Gut Colonization with Intrinsically Vancomycin-Resistant Enterococci (E. gallinarum and E. casseliflavus) and Outcomes of Allogeneic Hematopoietic Cell Transplantation.

Authors:  Armin Rashidi; Maryam Ebadi; Robin R Shields-Cutler; Todd E DeFor; Gabriel A Al-Ghalith; Patricia Ferrieri; Jo-Anne H Young; Gary M Dunny; Dan Knights; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2018-01-31       Impact factor: 5.742

7.  Use of molecular and reference susceptibility testing methods in a multicenter evaluation of MicroScan dried overnight gram-positive MIC panels for detection of vancomycin and high-level aminoglycoside resistances in enterococci.

Authors:  Y S Chen; S A Marshall; P L Winokur; S L Coffman; W W Wilke; P R Murray; C A Spiegel; M A Pfaller; G V Doern; R N Jones
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

8.  Enterococcus casseliflavus endophthalmitis due to metallic intraocular foreign body.

Authors:  J R Low; C S Teoh; J M F Chien; E H Huang
Journal:  Eye (Lond)       Date:  2015-02-06       Impact factor: 3.775

9.  Comparison of simple and rapid methods for identifying enterococci intrinsically resistant to vancomycin.

Authors:  K L Hanson; C P Cartwright
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

10.  Convenient selective differential broth for isolation of vancomycin-resistant enterococcus from fecal material.

Authors:  Thomas J Novicki; Jeffrey M Schapiro; Bruce K Ulness; Ann Sebeste; Laurel Busse-Johnston; Kristine M Swanson; Susan R Swanzy; Wendy Leisenring; Ajit P Limaye
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.